During the past decade, Jordan Hospital Club Cancer Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 8 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jordan Hospital Club Cancer Center" #1 sponsor was "NSABP Foundation Inc" with 5 trials, followed by "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored, "Alliance Foundation Trials, LLC." with 1 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jordan Hospital Club Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Jordan Hospital Club Cancer Center" are "Breast Cancer" (6 trials), "Pain" (2 trials), "Breast Adenocarcinoma" (1 trials), "Cardiac Toxicity" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Jordan Hospital Club Cancer Center" in a lesser frequency.

Most popular intervention types in "Jordan Hospital Club Cancer Center" are "Drug" (9 trials), "Other" (4 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Carboplatin" (1 trials), "Coreg CR®" (1 trials), "Letrozole" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jordan Hospital Club Cancer Center" are 5 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Jordan Hospital Club Cancer Center". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Jordan Hospital Club Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jordan Hospital Club Cancer Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".